Efficacy and safety of concomitant use of proton pump inhibitors with aspirin-clopidogrel dual antiplatelet therapy in coronary heart disease: A systematic review and meta-analysis

Background: Proton pump inhibitors (PPIs) are usually prescribed to prevent gastrointestinal (GI) complications in patients receiving dual antiplatelet therapy (DAPT). This systematic review and meta-analysis aimed to explore the efficacy and safety of the concomitant use of PPIs with aspirin-clopid...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Xiaofeng, Hou, Min, He, Shuangshuang, Yang, Xue, Zhang, Pan, Zhao, Yingxin, Xing, Haiyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871580/
https://www.ncbi.nlm.nih.gov/pubmed/36703730
http://dx.doi.org/10.3389/fphar.2022.1021584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871580/
https://www.ncbi.nlm.nih.gov/pubmed/36703730
http://dx.doi.org/10.3389/fphar.2022.1021584

Ejemplares similares